ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Valganciclovir Market Insights, Forecast to 2030
Published Date: September 2024
|
Report Code: QYRE-Auto-35E7702
Home | Market Reports | Health| Pharmacy
Global Valganciclovir Market Insights and Forecast to 2028
BUY CHAPTERS

Global Valganciclovir Market Insights, Forecast to 2030

Code: QYRE-Auto-35E7702
Report
September 2024
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Rakshit Drugs
United Biotech Private Limited
Roche

Valganciclovir Market Size

The global Valganciclovir market is projected to grow from US$ 232 million in 2024 to US$ 325.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period.

Valganciclovir Market

Valganciclovir Market

Valganciclovir is an antiviral. It is used to treat infections caused by viruses. This medicine is also used to prevent CMV disease in patients who have received an organ transplant (eg, heart, kidney, or kidney-pancreas transplant).
On the basis of region, the valganciclovir market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the valganciclovir market. This can be attributed to the rising prevalence of Valganciclovir-resistant cytomegalovirus (CMV) and the increasing demand for oral drugs in this region. Latin America is projected to grow at a significant rate during the forecast period owing to the rising prevalence of Valganciclovir-resistant cytomegalovirus (CMV) and the increasing demand for oral drugs in this region.
Report Covers:
This report presents an overview of global market for Valganciclovir, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Valganciclovir, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Valganciclovir, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Valganciclovir sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Valganciclovir market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Valganciclovir sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Valganciclovir Market Report

Report Metric Details
Report Name Valganciclovir Market
Accounted market size in 2024 US$ 232 million
Forecasted market size in 2030 US$ 325.4 million
CAGR 5.8
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • Powder
  • Tablet
Segment by Application
  • Adults
  • Children
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Valganciclovir in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Valganciclovir manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Valganciclovir sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Valganciclovir Market growing?

Ans: The Valganciclovir Market witnessing a CAGR of 5.8 during the forecast period 2024-2030.

What is the Valganciclovir Market size in 2030?

Ans: The Valganciclovir Market size in 2030 will be US$ 325.4 million.

Who are the main players in the Valganciclovir Market report?

Ans: The main players in the Valganciclovir Market are Roche

What are the Application segmentation covered in the Valganciclovir Market report?

Ans: The Applications covered in the Valganciclovir Market report are Adults, Children

What are the Type segmentation covered in the Valganciclovir Market report?

Ans: The Types covered in the Valganciclovir Market report are Powder, Tablet

Recommended Reports

Antiviral & Infection Drugs

Virus & Viral Diagnostics

Gene & Cell Therapies

1 Study Coverage
1.1 Valganciclovir Product Introduction
1.2 Market by Type
1.2.1 Global Valganciclovir Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Powder
1.2.3 Tablet
1.3 Market by Application
1.3.1 Global Valganciclovir Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Adults
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Valganciclovir Sales Estimates and Forecasts 2019-2030
2.2 Global Valganciclovir Revenue by Region
2.2.1 Global Valganciclovir Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Valganciclovir Revenue by Region (2019-2024)
2.2.3 Global Valganciclovir Revenue by Region (2025-2030)
2.2.4 Global Valganciclovir Revenue Market Share by Region (2019-2030)
2.3 Global Valganciclovir Sales Estimates and Forecasts 2019-2030
2.4 Global Valganciclovir Sales by Region
2.4.1 Global Valganciclovir Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Valganciclovir Sales by Region (2019-2024)
2.4.3 Global Valganciclovir Sales by Region (2025-2030)
2.4.4 Global Valganciclovir Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Valganciclovir Sales by Manufacturers
3.1.1 Global Valganciclovir Sales by Manufacturers (2019-2024)
3.1.2 Global Valganciclovir Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Valganciclovir in 2023
3.2 Global Valganciclovir Revenue by Manufacturers
3.2.1 Global Valganciclovir Revenue by Manufacturers (2019-2024)
3.2.2 Global Valganciclovir Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Valganciclovir Revenue in 2023
3.3 Global Key Players of Valganciclovir, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Valganciclovir Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Valganciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Valganciclovir, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Valganciclovir, Product Offered and Application
3.8 Global Key Manufacturers of Valganciclovir, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Valganciclovir Sales by Type
4.1.1 Global Valganciclovir Historical Sales by Type (2019-2024)
4.1.2 Global Valganciclovir Forecasted Sales by Type (2025-2030)
4.1.3 Global Valganciclovir Sales Market Share by Type (2019-2030)
4.2 Global Valganciclovir Revenue by Type
4.2.1 Global Valganciclovir Historical Revenue by Type (2019-2024)
4.2.2 Global Valganciclovir Forecasted Revenue by Type (2025-2030)
4.2.3 Global Valganciclovir Revenue Market Share by Type (2019-2030)
4.3 Global Valganciclovir Price by Type
4.3.1 Global Valganciclovir Price by Type (2019-2024)
4.3.2 Global Valganciclovir Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Valganciclovir Sales by Application
5.1.1 Global Valganciclovir Historical Sales by Application (2019-2024)
5.1.2 Global Valganciclovir Forecasted Sales by Application (2025-2030)
5.1.3 Global Valganciclovir Sales Market Share by Application (2019-2030)
5.2 Global Valganciclovir Revenue by Application
5.2.1 Global Valganciclovir Historical Revenue by Application (2019-2024)
5.2.2 Global Valganciclovir Forecasted Revenue by Application (2025-2030)
5.2.3 Global Valganciclovir Revenue Market Share by Application (2019-2030)
5.3 Global Valganciclovir Price by Application
5.3.1 Global Valganciclovir Price by Application (2019-2024)
5.3.2 Global Valganciclovir Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Valganciclovir Market Size by Type
6.1.1 US & Canada Valganciclovir Sales by Type (2019-2030)
6.1.2 US & Canada Valganciclovir Revenue by Type (2019-2030)
6.2 US & Canada Valganciclovir Market Size by Application
6.2.1 US & Canada Valganciclovir Sales by Application (2019-2030)
6.2.2 US & Canada Valganciclovir Revenue by Application (2019-2030)
6.3 US & Canada Valganciclovir Market Size by Country
6.3.1 US & Canada Valganciclovir Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Valganciclovir Sales by Country (2019-2030)
6.3.3 US & Canada Valganciclovir Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Valganciclovir Market Size by Type
7.1.1 Europe Valganciclovir Sales by Type (2019-2030)
7.1.2 Europe Valganciclovir Revenue by Type (2019-2030)
7.2 Europe Valganciclovir Market Size by Application
7.2.1 Europe Valganciclovir Sales by Application (2019-2030)
7.2.2 Europe Valganciclovir Revenue by Application (2019-2030)
7.3 Europe Valganciclovir Market Size by Country
7.3.1 Europe Valganciclovir Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Valganciclovir Sales by Country (2019-2030)
7.3.3 Europe Valganciclovir Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Valganciclovir Market Size
8.1.1 China Valganciclovir Sales (2019-2030)
8.1.2 China Valganciclovir Revenue (2019-2030)
8.2 China Valganciclovir Market Size by Application
8.2.1 China Valganciclovir Sales by Application (2019-2030)
8.2.2 China Valganciclovir Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Valganciclovir Market Size by Type
9.1.1 Asia Valganciclovir Sales by Type (2019-2030)
9.1.2 Asia Valganciclovir Revenue by Type (2019-2030)
9.2 Asia Valganciclovir Market Size by Application
9.2.1 Asia Valganciclovir Sales by Application (2019-2030)
9.2.2 Asia Valganciclovir Revenue by Application (2019-2030)
9.3 Asia Valganciclovir Sales by Region
9.3.1 Asia Valganciclovir Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Valganciclovir Revenue by Region (2019-2030)
9.3.3 Asia Valganciclovir Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Valganciclovir Market Size by Type
10.1.1 Middle East, Africa and Latin America Valganciclovir Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Valganciclovir Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Valganciclovir Market Size by Application
10.2.1 Middle East, Africa and Latin America Valganciclovir Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Valganciclovir Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Valganciclovir Sales by Country
10.3.1 Middle East, Africa and Latin America Valganciclovir Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Valganciclovir Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Valganciclovir Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Rakshit Drugs
11.1.1 Rakshit Drugs Company Information
11.1.2 Rakshit Drugs Overview
11.1.3 Rakshit Drugs Valganciclovir Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Rakshit Drugs Valganciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Rakshit Drugs Recent Developments
11.2 United Biotech Private Limited
11.2.1 United Biotech Private Limited Company Information
11.2.2 United Biotech Private Limited Overview
11.2.3 United Biotech Private Limited Valganciclovir Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 United Biotech Private Limited Valganciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 United Biotech Private Limited Recent Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Overview
11.3.3 Roche Valganciclovir Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Roche Valganciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Valganciclovir Industry Chain Analysis
12.2 Valganciclovir Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Valganciclovir Production Mode & Process
12.4 Valganciclovir Sales and Marketing
12.4.1 Valganciclovir Sales Channels
12.4.2 Valganciclovir Distributors
12.5 Valganciclovir Customers
13 Market Dynamics
13.1 Valganciclovir Industry Trends
13.2 Valganciclovir Market Drivers
13.3 Valganciclovir Market Challenges
13.4 Valganciclovir Market Restraints
14 Key Findings in The Global Valganciclovir Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Rakshit Drugs
United Biotech Private Limited
Roche
List of Tables
    Table 1. Global Valganciclovir Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Powder
    Table 3. Major Manufacturers of Tablet
    Table 4. Global Valganciclovir Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Valganciclovir Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Valganciclovir Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Valganciclovir Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Valganciclovir Revenue Market Share by Region (2019-2024)
    Table 9. Global Valganciclovir Revenue Market Share by Region (2025-2030)
    Table 10. Global Valganciclovir Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Valganciclovir Sales by Region (2019-2024) & (K Units)
    Table 12. Global Valganciclovir Sales by Region (2025-2030) & (K Units)
    Table 13. Global Valganciclovir Sales Market Share by Region (2019-2024)
    Table 14. Global Valganciclovir Sales Market Share by Region (2025-2030)
    Table 15. Global Valganciclovir Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Valganciclovir Sales Share by Manufacturers (2019-2024)
    Table 17. Global Valganciclovir Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Valganciclovir Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Valganciclovir, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Valganciclovir Price by Manufacturers 2019-2024 (USD/Unit)
    Table 21. Global Valganciclovir Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Valganciclovir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valganciclovir as of 2023)
    Table 23. Global Key Manufacturers of Valganciclovir, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Valganciclovir, Product Offered and Application
    Table 25. Global Key Manufacturers of Valganciclovir, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Valganciclovir Sales by Type (2019-2024) & (K Units)
    Table 28. Global Valganciclovir Sales by Type (2025-2030) & (K Units)
    Table 29. Global Valganciclovir Sales Share by Type (2019-2024)
    Table 30. Global Valganciclovir Sales Share by Type (2025-2030)
    Table 31. Global Valganciclovir Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Valganciclovir Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Valganciclovir Revenue Share by Type (2019-2024)
    Table 34. Global Valganciclovir Revenue Share by Type (2025-2030)
    Table 35. Valganciclovir Price by Type (2019-2024) & (USD/Unit)
    Table 36. Global Valganciclovir Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 37. Global Valganciclovir Sales by Application (2019-2024) & (K Units)
    Table 38. Global Valganciclovir Sales by Application (2025-2030) & (K Units)
    Table 39. Global Valganciclovir Sales Share by Application (2019-2024)
    Table 40. Global Valganciclovir Sales Share by Application (2025-2030)
    Table 41. Global Valganciclovir Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Valganciclovir Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Valganciclovir Revenue Share by Application (2019-2024)
    Table 44. Global Valganciclovir Revenue Share by Application (2025-2030)
    Table 45. Valganciclovir Price by Application (2019-2024) & (USD/Unit)
    Table 46. Global Valganciclovir Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 47. US & Canada Valganciclovir Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Valganciclovir Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Valganciclovir Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Valganciclovir Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Valganciclovir Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Valganciclovir Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Valganciclovir Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Valganciclovir Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Valganciclovir Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Valganciclovir Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Valganciclovir Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Valganciclovir Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Valganciclovir Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Valganciclovir Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Valganciclovir Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Valganciclovir Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Valganciclovir Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Valganciclovir Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Valganciclovir Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Valganciclovir Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Valganciclovir Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Valganciclovir Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Valganciclovir Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Valganciclovir Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Valganciclovir Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Valganciclovir Sales by Country (2025-2030) & (K Units)
    Table 73. China Valganciclovir Sales by Type (2019-2024) & (K Units)
    Table 74. China Valganciclovir Sales by Type (2025-2030) & (K Units)
    Table 75. China Valganciclovir Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Valganciclovir Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Valganciclovir Sales by Application (2019-2024) & (K Units)
    Table 78. China Valganciclovir Sales by Application (2025-2030) & (K Units)
    Table 79. China Valganciclovir Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Valganciclovir Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Valganciclovir Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Valganciclovir Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Valganciclovir Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Valganciclovir Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Valganciclovir Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Valganciclovir Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Valganciclovir Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Valganciclovir Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Valganciclovir Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Valganciclovir Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Valganciclovir Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Valganciclovir Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Valganciclovir Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Valganciclovir Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Valganciclovir Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Valganciclovir Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Valganciclovir Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Valganciclovir Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Valganciclovir Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Valganciclovir Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Valganciclovir Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Valganciclovir Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Valganciclovir Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Valganciclovir Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Valganciclovir Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Valganciclovir Sales by Country (2025-2030) & (K Units)
    Table 107. Rakshit Drugs Company Information
    Table 108. Rakshit Drugs Description and Major Businesses
    Table 109. Rakshit Drugs Valganciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Rakshit Drugs Valganciclovir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Rakshit Drugs Recent Developments
    Table 112. United Biotech Private Limited Company Information
    Table 113. United Biotech Private Limited Description and Major Businesses
    Table 114. United Biotech Private Limited Valganciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. United Biotech Private Limited Valganciclovir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. United Biotech Private Limited Recent Developments
    Table 117. Roche Company Information
    Table 118. Roche Description and Major Businesses
    Table 119. Roche Valganciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Roche Valganciclovir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Roche Recent Developments
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Valganciclovir Distributors List
    Table 125. Valganciclovir Customers List
    Table 126. Valganciclovir Market Trends
    Table 127. Valganciclovir Market Drivers
    Table 128. Valganciclovir Market Challenges
    Table 129. Valganciclovir Market Restraints
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Valganciclovir Product Picture
    Figure 2. Global Valganciclovir Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Valganciclovir Market Share by Type in 2023 & 2030
    Figure 4. Powder Product Picture
    Figure 5. Tablet Product Picture
    Figure 6. Global Valganciclovir Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Valganciclovir Market Share by Application in 2023 & 2030
    Figure 8. Adults
    Figure 9. Children
    Figure 10. Valganciclovir Report Years Considered
    Figure 11. Global Valganciclovir Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Valganciclovir Revenue 2019-2030 (US$ Million)
    Figure 13. Global Valganciclovir Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 14. Global Valganciclovir Revenue Market Share by Region (2019-2030)
    Figure 15. Global Valganciclovir Sales 2019-2030 ((K Units)
    Figure 16. Global Valganciclovir Sales Market Share by Region (2019-2030)
    Figure 17. US & Canada Valganciclovir Sales YoY (2019-2030) & (K Units)
    Figure 18. US & Canada Valganciclovir Revenue YoY (2019-2030) & (US$ Million)
    Figure 19. Europe Valganciclovir Sales YoY (2019-2030) & (K Units)
    Figure 20. Europe Valganciclovir Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. China Valganciclovir Sales YoY (2019-2030) & (K Units)
    Figure 22. China Valganciclovir Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Asia (excluding China) Valganciclovir Sales YoY (2019-2030) & (K Units)
    Figure 24. Asia (excluding China) Valganciclovir Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Middle East, Africa and Latin America Valganciclovir Sales YoY (2019-2030) & (K Units)
    Figure 26. Middle East, Africa and Latin America Valganciclovir Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. The Valganciclovir Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 28. The Top 5 and 10 Largest Manufacturers of Valganciclovir in the World: Market Share by Valganciclovir Revenue in 2023
    Figure 29. Global Valganciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 30. Global Valganciclovir Sales Market Share by Type (2019-2030)
    Figure 31. Global Valganciclovir Revenue Market Share by Type (2019-2030)
    Figure 32. Global Valganciclovir Sales Market Share by Application (2019-2030)
    Figure 33. Global Valganciclovir Revenue Market Share by Application (2019-2030)
    Figure 34. US & Canada Valganciclovir Sales Market Share by Type (2019-2030)
    Figure 35. US & Canada Valganciclovir Revenue Market Share by Type (2019-2030)
    Figure 36. US & Canada Valganciclovir Sales Market Share by Application (2019-2030)
    Figure 37. US & Canada Valganciclovir Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Valganciclovir Revenue Share by Country (2019-2030)
    Figure 39. US & Canada Valganciclovir Sales Share by Country (2019-2030)
    Figure 40. U.S. Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 41. Canada Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 42. Europe Valganciclovir Sales Market Share by Type (2019-2030)
    Figure 43. Europe Valganciclovir Revenue Market Share by Type (2019-2030)
    Figure 44. Europe Valganciclovir Sales Market Share by Application (2019-2030)
    Figure 45. Europe Valganciclovir Revenue Market Share by Application (2019-2030)
    Figure 46. Europe Valganciclovir Revenue Share by Country (2019-2030)
    Figure 47. Europe Valganciclovir Sales Share by Country (2019-2030)
    Figure 48. Germany Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 49. France Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 50. U.K. Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 51. Italy Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 52. Russia Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 53. China Valganciclovir Sales Market Share by Type (2019-2030)
    Figure 54. China Valganciclovir Revenue Market Share by Type (2019-2030)
    Figure 55. China Valganciclovir Sales Market Share by Application (2019-2030)
    Figure 56. China Valganciclovir Revenue Market Share by Application (2019-2030)
    Figure 57. Asia Valganciclovir Sales Market Share by Type (2019-2030)
    Figure 58. Asia Valganciclovir Revenue Market Share by Type (2019-2030)
    Figure 59. Asia Valganciclovir Sales Market Share by Application (2019-2030)
    Figure 60. Asia Valganciclovir Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Valganciclovir Revenue Share by Region (2019-2030)
    Figure 62. Asia Valganciclovir Sales Share by Region (2019-2030)
    Figure 63. Japan Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 64. South Korea Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 65. China Taiwan Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 66. Southeast Asia Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 67. India Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 68. Middle East, Africa and Latin America Valganciclovir Sales Market Share by Type (2019-2030)
    Figure 69. Middle East, Africa and Latin America Valganciclovir Revenue Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Valganciclovir Sales Market Share by Application (2019-2030)
    Figure 71. Middle East, Africa and Latin America Valganciclovir Revenue Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Valganciclovir Revenue Share by Country (2019-2030)
    Figure 73. Middle East, Africa and Latin America Valganciclovir Sales Share by Country (2019-2030)
    Figure 74. Brazil Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 75. Mexico Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 76. Turkey Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 77. Israel Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 78. GCC Countries Valganciclovir Revenue (2019-2030) & (US$ Million)
    Figure 79. Valganciclovir Value Chain
    Figure 80. Valganciclovir Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Valganciclovir API Market Research Report 2025
Global Valganciclovir Tablets Market Research Report 2024
Global Valganciclovir Hcl API Market Research Report 2025
Global Valacyclovir API Market Research Report 2025
Global Cytomegalovirus HHV 5 Infection Therapeutic Drugs Market Insights Forecast to 2030
Global Aciclovir Market Research Report 2024
Global Cytomegalovirus Disease Treatments Market Research Report 2024
Global Cytomegalovirus Retinitis Treatment Market Research Report 2024
Global Cytomegalovirus CMV Treatment Drugs Market Research Report 2024
Global Cytomegalovirus Treatment Market Research Report 2024
Global Cytomegalovirus Immune Globulin Intravenous Human CMV IGIV Market Research Report 2024
Cytomegalovirus Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Papillomavirus and Cytomegalovirus Therapeutics Market Research Report 2024
Global Valacyclovir Market Research Report 2024
Valaciclovir HCl Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Valacyclovir Hydrochloride Market Research Report 2025
Global Letermovir API Market Research Report 2024
Global Cyclosporine Drugs Market Research Report 2025
Global Valacyclovir Hcl API Market Research Report 2025
Global Penciclovir Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions